Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Amgen
- 10 Jun 2017 Biomarkers information updated
- 21 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov record.